Compare PRPO & ACCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | ACCL |
|---|---|---|
| Founded | N/A | 2009 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Professional Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.0M | 36.3M |
| IPO Year | 2000 | 2024 |
| Metric | PRPO | ACCL |
|---|---|---|
| Price | $23.21 | $2.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 84.8K | 15.4K |
| Earning Date | 11-13-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,049,000.00 | N/A |
| Revenue This Year | $233.72 | N/A |
| Revenue Next Year | $22.61 | N/A |
| P/E Ratio | ★ N/A | $17.13 |
| Revenue Growth | ★ 29.77 | N/A |
| 52 Week Low | $16.40 | $1.23 |
| 52 Week High | $33.63 | $5.00 |
| Indicator | PRPO | ACCL |
|---|---|---|
| Relative Strength Index (RSI) | 40.20 | 41.05 |
| Support Level | $22.09 | $2.42 |
| Resistance Level | $24.95 | $3.16 |
| Average True Range (ATR) | 1.18 | 0.20 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 18.10 | 46.21 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.